MR
Mohammed Rafi Syed
About Mohammed Rafi Syed
Data last updated:
Mohammed Rafi Syed is a Director at I4 Humanitad India Private Limited (since 2019), Director at Ayurjeeva Pharma (India) Private Limited (since 2017) and Director at Ifar Builders And Developers Private Limited (since 2009). The companies operate in Real Estate and Construction, Business Services and Construction.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Apr 2019 | 2017 | Active | ||
| Director | 20 Oct 2017 | 2017 | Active | ||
| Director | 22 Sep 2009 | 2009 | Active |
Board colleagues of Mohammed Rafi Syed
| Name | DIN | Company | Designation |
|---|---|---|---|
| Salim Muppadittiparambil Mohamed | 01652015 | I4 Humanitad India Private Limited | Director |
| Razia Beevi Ramla | 02722202 | Ayurjeeva Pharma (India) Private Limited , Ifar Builders And Developers Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammed Rafi Syed
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammed Rafi Syed
Mohammed Rafi Syed currently holds 3 directorships: I4 Humanitad India Private Limited (Director, since 29 Apr 2019); Ayurjeeva Pharma (India) Private Limited (Director, since 20 Oct 2017); Ifar Builders And Developers Private Limited (Director, since 22 Sep 2009).
Mohammed Rafi Syed was first appointed on 22 Sep 2009 as Director at Ifar Builders And Developers Private Limited. The most recent appointment on record is 29 Apr 2019 at I4 Humanitad India Private Limited.
The current boards of Mohammed Rafi Syed's companies include Salim Muppadittiparambil Mohamed (I4 Humanitad India Private Limited), Razia Beevi Ramla (Ayurjeeva Pharma (India) Private Limited).